Crossmark

The efficacy of Sarcomeal® oral supplementation plus vitamin D3 on muscle parameters, metabolic factors, and quality of life in diabetic sarcopenia: a randomized controlled clinical trial

Crossref DOI link: https://doi.org/10.1007/s40520-025-02969-x

Published Online: 2025-03-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abdi Dezfouli, Ramin

Zargar Balajam, Narges

Heshmat, Ramin

Shafiee, Gita
Funding

Funding for this research was provided by:

Tehran University of Medical Sciences and Health Services (1402-02-221-67485)
License Information

Text and Data Mining valid from 2025-03-13

Version of Record valid from 2025-03-13
More Information

Article History

Received: 8 October 2024

Accepted: 11 February 2025

First Online: 13 March 2025

Declarations

:

: This study is approved by the institutional ethics committee of the Endocrine and Metabolism Research Institute, Tehran University of Medical Sciences (IR.TUMS.EMRI.REC.1402.071).

: All the patients included in this study provided written consent before they got involved in the study. All the participants’ personal data and information remain confidential.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below